Drugs / Procainamide
Procainamide
also known as
Amidoprocaine · Biocoryl · Cardiorytmin · Novocainamid · Novocainamide · NSC-27461 · NSC-757279 · Procainamida · +10 more
Regulatory milestones approvals, filings & regulatory actions · 3 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansions (2) | US (FDA) | PRONESTYL | — | 1991-10-03 – 2009-03-13 | fda.gov ↗ |
| Approved | US (FDA) | PRONESTYL | — | 1950-06-02 | fda.gov ↗ |
Trials 5
194919501951195219531954195519561957195819591960196119621963196419651966196719681969197019711972197319741975197619771978197919801981198219831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 33 trials | ||||||
| Phase 3 | NCT00000556 | Mar 1995 → Sep 2002 | atrial fibrillation | National Heart, Lung, and Blood Institute (NHLBI) | Completed | No outcome recorded |
| Phase 3 | NCT00000464 | Apr 1987 → Dec 1992 | cardiac arrest, myocardial infarction, ventricular fibrillation | University of Washington | Completed | No outcome recorded |
| Phase 3 | NCT00000518 | Jul 1985 → Dec 1992 | sudden cardiac arrest, ventricular fibrillation, ventricular tachycardia | University of Utah | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT02575534 | Oct 2015 → Feb 2018 | cardiac rhythm disease | Evan Adelstein, MD | Withdrawn | No outcome recorded Stop: Enrollment |
| — | NCT01205529 | Nov 2010 → Jun 2015 | atrial fibrillation | Vanderbilt University Medical Center | Completed | No outcome recorded |
| Comparator or background therapy7 trials | ||||||
| Phase 3 | NCT01994070 Comparator | Nov 2013 → Mar 2015 | atrial fibrillation | University of British Columbia | Completed | No outcome recorded |
| Phase 3 | NCT00589303 Comparator | Dec 2007 → Jul 2011 | atrial fibrillation, heart failure | Mayo Clinic | Terminated | No outcome recorded Stop: Business |
| Phase 4 | NCT04234906 Comparator | Jan → Apr 2023 | cardiac rhythm disease, congenital anomaly of cardiovascular system | Jeffrey Moak | Unknown | No outcome recorded |
| Phase 4 | NCT04485195 Comparator | Jun 2021 → Sep 2024 | atrial fibrillation | Ottawa Hospital Research Institute | Completed | No outcome recorded |
| Phase 4 | NCT02114528 Comparator | Oct 2014 → Nov 2015 | ventricular tachycardia | Ottawa Heart Institute Research Corporation | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT00702117 Comparator | Jun 2008 → Jan 2010 | Brugada syndrome, atrial fibrillation, ventricular tachycardia | Hospital Clinic of Barcelona | Completed | No outcome recorded |
| Phase 4 | NCT00383799 Comparator | Sep 2005 → Jun 2011 | ventricular tachycardia | Hospital General Universitario Gregorio Marañon | Terminated | No outcome recorded |
Evidence & citations 21 cited values
Every value below carries the sentence it was read from. 13 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | procainamide | “Either one or more of the following antiarrhythmic drugs: sotalol, mexiletine, procainamide, or amiodarone.” NCT02114528 ↗11“* procainamide * quinidine * disopyramide * propafenone * flecainide * sotalol * dofetilide * amiodarone” NCT00589303 ↗ “receive intravenous procainamide 17 mg / kg over 30 minutes.” NCT01994070 ↗ |
| Known as | Amidoprocaine | ChEMBL registry synonym — accepted as the source's own label CHEMBL640 ↗ |
| Known as | Biocoryl | ChEMBL registry synonym — accepted as the source's own label CHEMBL640 ↗ |
| Known as | Cardiorytmin | ChEMBL registry synonym — accepted as the source's own label CHEMBL640 ↗ |
| Known as | Novocainamid | ChEMBL registry synonym — accepted as the source's own label CHEMBL640 ↗ |
| Known as | Novocainamide | ChEMBL registry synonym — accepted as the source's own label CHEMBL640 ↗ |
| Known as | NSC-27461 | ChEMBL registry synonym — accepted as the source's own label CHEMBL640 ↗ |
| Known as | NSC-757279 | ChEMBL registry synonym — accepted as the source's own label CHEMBL640 ↗ |
| Known as | Procainamida | ChEMBL registry synonym — accepted as the source's own label CHEMBL640 ↗ |
| Known as | Procainamide hcl | ChEMBL registry synonym — accepted as the source's own label CHEMBL640 ↗ |
| Known as | PROCAINAMIDE HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL640 ↗ |
| Known as | Procainamidi hydrochloridum | ChEMBL registry synonym — accepted as the source's own label CHEMBL640 ↗ |
| Known as | Procan | ChEMBL registry synonym — accepted as the source's own label CHEMBL640 ↗ |
| Known as | Procan sr | ChEMBL registry synonym — accepted as the source's own label CHEMBL640 ↗ |
| Known as | Procanbid | ChEMBL registry synonym — accepted as the source's own label CHEMBL640 ↗ |
| Known as | Procapan | ChEMBL registry synonym — accepted as the source's own label CHEMBL640 ↗ |
| Known as | Pronestyl | ChEMBL registry synonym — accepted as the source's own label CHEMBL640 ↗ |
| Known as | Pronestyl-sr | ChEMBL registry synonym — accepted as the source's own label CHEMBL640 ↗ |
| Known as | Sp 100 (pharmaceutical) | ChEMBL registry synonym — accepted as the source's own label CHEMBL640 ↗ |
| Modality | Small molecule | — CHEMBL640 ↗ |
| Route | Intravenous | “IV procainamide” NCT00383799 ↗ |